GT Biopharma Other Long Term Liabilities (Quarterly) Analysis

GT Biopharma, Inc. (GTBP)

0.6648 -0.02 (-3.01%) USD | NASDAQ | Jan 14, 12:25

View Other Long Term Liabilities (Quarterly) for GTBP.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Regeneron Pharmaceuticals, Inc.	Upgrade
SELLAS Life Sciences Group, Inc.	--
Lyell Immunopharma, Inc.	Upgrade
Plus Therapeutics, Inc.	--
Geron Corp.	Upgrade